Salesmotion
Book a demo

Alternatives

Top 5 Clarivate Alternatives for Life Sciences Teams (2026)

Compare the best alternatives to Clarivate's Life Sciences & Healthcare products — from proprietary pipeline databases to AI-powered account intelligence platforms.

Book a demoTry interactive demo
G24.8 rating on G2
Semir JahicBy Semir JahicCEO & Co-Founder, SalesmotionLast reviewed
At a glance

How Clarivate Alternatives Compare

Side-by-side comparison of the key capabilities that matter most.

FeatureSalesmotionCitelineAlphaSenseGlobalDataEvaluate (Norstella)
Primary FocusAI account intelligence & selling signalsDrug pipeline & clinical trial databasesAI document search & expert interviewsBroad market intelligence & reportsDrug-sales forecasting and commercial intelligence
Clinical Trial DataScans & consolidates trials globally from ClinicalTrials.gov + public registries60,000+ sources, proprietary Trialtrove databaseClinicalTrials.gov + PubMed searchIntegrated trial intelligence modulePipeline and trial data linked to forecasts
Buying Signals24/7 monitoring across 1,000+ sourcesPipeline changes onlyWatchlists with real-time alertsLimited to report updatesNot a buying-signal tool; forecast and deal data
AI CapabilitiesAI briefs, talking points, outreach draftsElla AI assistant for pipeline queriesGenerative search with cited answersAI engine with predictive analyticsEvaluate Omnium ML risk/return modelling
Setup Time20 minutes — live same dayEnterprise onboarding (weeks)Days to weeks with trainingEnterprise onboarding (weeks)Weeks; enterprise onboarding
Pricing$85/mo for individuals. Custom pricing for teams & enterprise.Six figures annually (enterprise)$10K–$100K+/year per team$30K–$80K+/yearCustom, enterprise-only; not published
Best ForBD & sales teams needing account contextR&D & clinical ops needing pipeline dataCI teams needing document researchStrategy teams needing market reportsStrategy, corporate development, and finance teams
Rating (G2)4.8/54.2/54.7/5——

Why teams are evaluating Clarivate alternatives

In July 2026, Clarivate announced a definitive agreement to sell its Life Sciences & Healthcare division to Altaris LLC for $600 million, expected to close by the end of 2026. The LS&HC business — which includes Cortellis, DRG Fusion, and BioWorld — generated $389.8M in revenue in 2025, declining 6.9% year-over-year. This has prompted many life sciences teams to proactively evaluate alternatives before ownership transitions bring pricing and roadmap uncertainty.

The most common reasons teams look for Clarivate alternatives include high annual contract costs (six figures for most modules), long implementation timelines, and the growing realization that much of what commercial teams use Clarivate for — account research, competitive monitoring, meeting preparation — can be done faster and cheaper with AI-native tools that synthesize publicly available data.

The key distinction is between proprietary data needs and intelligence workflow needs. Teams that need structured regulatory filings, patient-level claims data, or curated drug pipeline metadata are looking at Citeline, IQVIA, or GlobalData. Teams that need account intelligence, buying signals, and outreach support for BD and sales are discovering that platforms like Salesmotion deliver most of what they need at a fraction of the cost.

Why Trust This Guide?

Semir Jahic, CEO & Co-Founder of Salesmotion

I'm Semir Jahic, CEO of Salesmotion. Last year we signed our first CRO customer, and since then we've added several more life sciences companies. I've seen firsthand how these teams were drowning in expensive, fragmented tools — and how much time they waste toggling between them. Cytel, a 2,000+ employee life sciences analytics company, consolidated five research sources — ZoomInfo, Crunchbase, SEC.gov, Google News and ClinicalTrials.gov — into Salesmotion and cut account research time by 50%. This guide comes from real conversations with life sciences commercial teams, not just feature matrix comparisons.

Semir Jahic — CEO & Co-Founder, Salesmotion

Detailed Breakdown

Best Clarivate Alternatives

An in-depth look at each platform, including features, pricing, and limitations.

1

Salesmotion

Our Pick
G2: 4.8/5 (25 reviews)

Salesmotion is an AI-powered account intelligence platform that helps life sciences BD and sales teams research accounts, track buying signals, and personalize outreach — all from publicly available data. It synthesizes intelligence from over 1,000 sources (news, earnings calls, job postings, press releases, clinical trial registries, leadership changes) into actionable account briefs with AI-generated talking points.

Salesmotion does not have proprietary internally curated clinical databases like Clarivate. However, it actively scans and consolidates clinical trial data globally from ClinicalTrials.gov and equivalent public registries worldwide — alongside real-time signal monitoring from 1,000+ other sources. Combined with AI-generated account context and a modern interface that takes 20 minutes to set up, it provides life sciences BD teams 80–90% of the account context they need for daily selling at roughly 80–90% less cost.

Cytel, a 2,000+ employee life sciences analytics company, is the flagship life sciences customer. They consolidated five research sources — ZoomInfo, Crunchbase, SEC.gov, Google News and ClinicalTrials.gov — into Salesmotion, cut account research time by 50%, and reduced account planning prep by 30%.

Best for:Life sciences BD and sales teams that need account intelligence, buying signals, and meeting prep without six-figure data contracts

Key Features

  • AI-generated account briefs from 1,000+ public sources — including global clinical trial data from ClinicalTrials.gov and public registries
  • Real-time buying signal monitoring — earnings, leadership changes, clinical trials, hiring, news
  • Cross-signal keyword search across all accounts and data types
  • AI-generated talking points and outreach drafts anchored to real events
  • Plug-and-play setup in 20 minutes — no IT project or integration required
  • Account-based for individuals; custom team & enterprise pricing

Limitations

  • No proprietary internally curated pipeline databases — tracks trials from public registries, not internal sources
  • No patient-level claims or real-world data
  • Smaller platform — newer entrant compared to legacy life sciences vendors
Pricing: $85/mo for individuals — flexible monthly billing. Custom pricing for teams and enterprise on request.
G24.8 rating on G2Book a demo
2

Citeline (Norstella)

G2: 4.2/5Visit site

Citeline is part of Norstella (alongside Evaluate and MMIT) and is the single most direct alternative to Clarivate's Cortellis suite. Its flagship products — Pharmaprojects, Trialtrove, and Sitetrove — cover drug pipeline intelligence, clinical trial operations, and site selection with deep proprietary data curated over 40+ years.

Citeline recently launched "+" tiers of its core products, adding the Ella AI assistant for natural-language pipeline queries, drug-similarity analysis, and enhanced analytics. The NorstellaLinQ platform integrates data across the Norstella family, linking pipeline data (Citeline) with commercial forecasts (Evaluate), payer data (MMIT), and RWD analytics (Panalgo).

For teams that need a like-for-like Cortellis replacement with proprietary curated data, Citeline is the most natural fit — but expect similar enterprise pricing and implementation timelines.

Best for:Pharma R&D, clinical operations, and BD teams that need a direct Cortellis replacement with proprietary pipeline and trial databases

Key Features

  • 90,000+ drug profiles with 40+ years of continuous pipeline data (Pharmaprojects)
  • Clinical trial intelligence from 60,000+ data sources (Trialtrove)
  • Ella AI assistant for natural-language pipeline and trial queries
  • Site selection benchmarking and performance data (Sitetrove)
  • NorstellaLinQ cross-product integration with Evaluate forecasts and MMIT payer data
  • Ask-The-Analyst service: unlimited access to therapeutic area experts

Limitations

  • Enterprise pricing comparable to Clarivate — not a cost-reduction move
  • Complex implementation requiring dedicated onboarding
  • NorstellaLinQ integration is still maturing across product lines
Pricing: Enterprise subscriptions, not publicly listed. Single modules typically mid-to-high five figures/year; multi-product bundles run six figures annually. Multi-year contracts common.
3

AlphaSense

G2: 4.7/5Visit site

AlphaSense is an AI-powered market intelligence platform that takes a fundamentally different approach from Clarivate. Rather than providing curated proprietary databases, AlphaSense uses generative AI to search, synthesize, and reason across 500M+ premium documents — equity research, earnings transcripts, FDA/EMA submissions, PubMed, ClinicalTrials.gov, expert interviews, and more.

For life sciences teams, the key differentiator is access to expert interviews (physicians, payers, industry executives) and the ability to ask natural-language questions across all documents with citation-backed answers. AlphaSense's Generative Grid feature lets teams build structured competitor comparisons from AI-extracted data.

AlphaSense surpassed $500M ARR in 2025 and serves 88% of the S&P 100, making it one of the fastest-growing intelligence platforms in the market.

Best for:Competitive intelligence, BD, and medical affairs teams that need AI-powered document research with expert interview access

Key Features

  • Generative AI search across 500M+ premium documents with citation traceability
  • Expert interview network — physician, payer, and industry executive transcripts
  • Generative Grid for structured AI-built competitor comparison tables
  • FDA, EMA, PubMed, and ClinicalTrials.gov integrated with commercial content
  • Watchlists and real-time alerts for companies, drugs, and therapeutic areas
  • Internal content integration — search proprietary reports alongside external data

Limitations

  • Not a structured pipeline database — relies on document extraction, not curated records
  • No real-world claims data or patient-level analytics
  • Premium tiers with expert interviews are expensive ($50K–$100K+/year)
Pricing: Annual enterprise subscriptions. Entry-level from $10,000–$20,000/seat/year. Enterprise deals with expert interviews and internal integration: $50,000–$100,000+/year.
4

GlobalData

Visit site

GlobalData provides broad market intelligence across pharmaceuticals, medtech, healthcare, and adjacent sectors. Its Pharmaceutical Intelligence Center covers drugs, trials, regulatory milestones, patents, deals, and market forecasting in one integrated platform — often at price points below Clarivate's bundled Cortellis suite.

GlobalData's strength is breadth: it links pharma data to medtech, digital health, and other sectors, making it useful for strategy teams that need cross-market views. Its 290+ proprietary datasets are built on primary research validated by 2,000+ in-house analysts. The POLI Strat module provides drug pricing and market access data with local expert commentary.

The trade-off is data depth. For deep therapeutic area analysis and regulatory granularity, Cortellis and Citeline are generally considered more comprehensive. GlobalData appeals to teams that need broad market mapping at a more accessible price point.

Best for:Strategy and BD teams that need broad cross-sector market intelligence at a more accessible price point than Cortellis

Key Features

  • Integrated pipeline, clinical trial, regulatory, patent, and commercial data
  • Cross-sector intelligence linking pharma to medtech, digital health, and adjacent markets
  • Drug pricing and market access database (POLI Strat) with local expert analysis
  • 290+ proprietary datasets covering the full pharma value chain
  • AI engine with predictive analytics across datasets
  • Enterprise subscription with organization-wide access

Limitations

  • Data depth is generally shallower than Cortellis or Citeline for specific therapeutic areas
  • Enterprise pricing still represents a significant commitment
  • Implementation and onboarding take weeks for full platform access
Pricing: Enterprise subscriptions. Annual contracts typically $30,000–$80,000+/year depending on module scope. Report library purchases available separately.
5

Evaluate (Norstella)

Visit site

Evaluate is a commercial-intelligence and forecasting business for life sciences, founded in 1996 and now part of Norstella — the same group as Citeline. It addresses the same buyer as Clarivate: teams inside pharma and biotech who need to understand a market rather than sell into one.

Its flagship, EvaluatePharma, is widely treated as the industry standard for consensus drug-sales forecasts, with 1.5M+ forecasts covering 10,000 products back to 2003, alongside indication-level sales, pipeline intelligence, and deal and patent tracking. Evaluate Omnium adds machine-learning risk and return analysis for individual assets.

Where Cortellis leans on curated R&D and regulatory metadata, Evaluate leans on forecasting and valuation. Strategy, corporate development, and finance teams use it for market sizing, portfolio comparison, and asset modelling.

Best for:Strategy, corporate development, and finance teams that need consensus forecasts, valuation inputs, and market sizing

Key Features

  • EvaluatePharma — consensus drug-sales forecasts treated as an industry standard
  • 1.5M+ forecasts across 10,000 products, dating back to 2003
  • Indication-level drug sales with pipeline, deal, and patent intelligence
  • Evaluate Omnium — ML risk/return and probability-of-success modelling
  • Market sizing and portfolio comparison across companies
  • Used across pharma, biotech, investment banks, and consultancies

Limitations

  • Built for forecasting and valuation rather than day-to-day commercial prospecting
  • No buying signals, contact data, or outreach — a research library rather than a selling platform
  • Enterprise-only pricing with no published tiers or self-service option
Pricing: Evaluate does not publish list pricing; contracts are quoted per organization; EvaluatePharma and Evaluate Omnium are quoted per organization.

Customer Story

How Cytel cut research time by 50% and consolidated 5 research sources into one

50%

less research time

5 → 1

research sources consolidated

30%

faster account planning

“All of the vendors that I've worked with, all of the onboarding that I have had to deal with, I will say, hands down, Salesmotion was the easiest that I have had.”

Lyndsay Thomson

Lyndsay Thomson

Head of Sales Operations, Cytel

Read the full case study

Founder's Take

“Let me be direct: Clarivate has proprietary internally curated data that we do not replicate — structured regulatory filings, analyst-annotated pipeline metadata, patient-level claims data. If your R&D or regulatory affairs team needs those datasets, you need Clarivate, Citeline, or IQVIA. But we do track clinical trials globally — we scan and consolidate data from ClinicalTrials.gov and public registries worldwide, alongside 1,000+ other sources. If your BD and sales team is paying six figures for what is essentially an expensive research interface, the calculus has changed. The question is not whether AI will displace legacy data vendors — it is which parts of their value prop are genuinely proprietary and which are just an interface over publicly available data.”
Semir Jahic

Semir Jahic

CEO & Co-Founder, Salesmotion

Summary

Key Takeaways

  1. 1Clarivate's Life Sciences & Healthcare division ($390M revenue) is being sold to Altaris LLC, announced July 2026, creating uncertainty for existing customers around pricing, roadmap, and support.
  2. 2Citeline (Norstella) is the most direct Cortellis replacement — deep drug pipeline and clinical trial databases with the new Ella AI assistant. Expect similar enterprise pricing.
  3. 3AlphaSense offers a fundamentally different approach: AI-powered search across 500M+ documents including expert interviews, at a wider range of price points ($10K–$100K+).
  4. 4GlobalData provides the broadest market coverage across pharma, medtech, and adjacent sectors — typically at lower price points than Cortellis ($30K–$80K+/year).
  5. 5Evaluate (Norstella) is the standard for consensus drug-sales forecasting — built for strategy, corp-dev, and finance rather than commercial prospecting.
  6. 6Salesmotion offers the widest business context at the lowest price point (from $85/mo). It scans and consolidates clinical trials globally from ClinicalTrials.gov and public registries — it just does not have proprietary internally curated metadata. For daily BD and selling workflows, it delivers 80–90% of the intelligence teams need — and Cytel proved it by consolidating five research sources — ZoomInfo, Crunchbase, SEC.gov, Google News and ClinicalTrials.gov — into one.
An honest take

Where Salesmotion isn't the right fit

We'd rather you pick the right tool than the wrong one. Salesmotion isn't for everyone — here's when another option on this page is the smarter call.

  • You need a built-in email sequencer or dialer. Salesmotion is account intelligence, not a sending tool — it's built to sit alongside Outreach, Salesloft, or Apollo, not replace them.
  • You're buying purely for raw contact volume. Dedicated data vendors like ZoomInfo and Apollo carry larger raw contact databases.
  • You want a free-forever tier. Salesmotion starts at $85/mo for individuals — there's no free plan.
  • Your motion is pure high-volume SMB outbound. The depth pays off most on considered, higher-ACV deals where understanding the account actually changes the conversation.

Ready to see a better way to sell?

Salesmotion replaces hours of manual research with real-time account intelligence your reps can use today.

Book a DemoSee Product Tour
Head-to-head comparisonClarivate vs Salesmotion — feature-by-feature
Product

See Salesmotion in Action

Salesmotion life sciences signal feed showing clinical trial, earnings, and news signals across pharma accounts
Real-time life sciences signals across your entire territory — clinical trials, earnings, leadership changes, and more.
Salesmotion AI-generated account brief for a pharma company showing key insights and talking points
AI-generated account briefs synthesize intelligence from 1,000+ public sources in one click.
FAQ

Frequently Asked Questions

What is the best Clarivate alternative for life sciences sales teams?

It depends on your primary need. If you need a direct Cortellis replacement with proprietary pipeline and trial databases, Citeline (Norstella) is the closest equivalent. If you need account intelligence, buying signals, and meeting prep for BD and sales at a fraction of the cost, Salesmotion delivers 80–90% of the value for daily selling workflows. See how Cytel consolidated five research sources — ZoomInfo, Crunchbase, SEC.gov, Google News and ClinicalTrials.gov — into Salesmotion.

How much cheaper are Clarivate alternatives?

Pricing ranges widely. Citeline matches Clarivate at six figures annually. AlphaSense starts at $10K–$20K/seat. GlobalData runs $30K–$80K+/year. Evaluate is enterprise-only and does not publish pricing. Salesmotion is the most affordable at $85/month for individuals, with custom team and enterprise pricing scaled to your account universe.

Can AI platforms replace Clarivate's proprietary data?

For some use cases, yes. AI-native platforms like Salesmotion and AlphaSense can synthesize clinical trial activity, earnings calls, regulatory news, and competitive intelligence from public sources — covering most of what BD and sales teams need for daily account work. But proprietary curated datasets (patient-level claims data, structured regulatory filings, deep drug pipeline metadata) remain a genuine moat that AI cannot replicate from public sources alone. The most cost-effective approach for many teams is keeping selective proprietary modules for R&D while using AI-native tools for commercial workflows.

What happens to Clarivate LS&HC customers if the division is sold?

Existing contracts will be honored regardless of ownership change. However, product roadmaps, pricing, and support models often shift after acquisitions — particularly PE acquisitions where cost optimization is a priority. This is exactly why many teams are proactively evaluating alternatives now, before the uncertainty peaks. Read our full analysis of the Clarivate sale.

Which alternative is best for CROs and CDMOs?

None of the Clarivate alternatives above are built for that job. Clarivate, Citeline, GlobalData and Evaluate all serve teams inside pharma who are analysing a market. CROs and CDMOs are selling services into pharma, which is a different motion needing buying signals, contacts and outreach rather than R&D metadata. Salesmotion covers that motion — signal coverage across earnings calls, SEC filings, hiring and strategic news, with verified contacts and drafted outreach. See sales intelligence for clinical research.

Related Comparisons

Explore more head-to-head comparisons and alternatives guides.

Clarivate vs SalesmotionGlobalData AlternativesEvaluate AlternativesClarivate LS&HC Sale Analysis

Give every rep three AI agents to build more pipeline.

A Signal Agent, Research Agent, and Outreach Agent — working 24/7 so your team spends less time researching and more time closing.

Book a demoOr try the interactive demo